Navigation Links
Novel Methods in Diagnosing Oral Cancer

graphy (ODT), which show surface and subsurface tissues at near-microscopic levels of resolution, with the potential for replacing conventional surgical biopsy and histopathology techniques.

Combined with polarimetry, accurate delineation of lesion margins becomes possible. Scanning is painless and non-invasive, lasting less than one minute with a pen-sized hand-held probe.

This device’s resolution or diagnostic capability may dictate its primary use as an indicator of the need for biopsy.

Later, this modality may progressively reduce the need for biopsy, define surgical margins, and permit the direct evaluation of cancer treatments. In combination with OCT-visible molecular probes, this modality will greatly advance cancer diagnostics.

Source-Eurekalert
AN
'"/>




Page: 1 2

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Novel Methods Diagnosing Oral Cancer

(Date:7/9/2008)... InsuranceSpecialists.com, ...otes for almost a decade, now offers comprehensive...n presidential candidates are taking on health ref...ertisement-free, supplies unbiased material on med...s to help consumers make the best choices in cover...
(Date:7/8/2008)...Cincinnati, OH, July 7, 2008Girls moving through a...ht gain, but the reasons for this are not always c...in are easily overlooked. A new study soon to be ...the effect of Internet usage, sleep, and alcohol a... girls. , Dr. Catherine Berkey and colleagues ...
(Date:7/8/2008)...ose who had phlebotomy were 37% less likely to dev...hDay News) -- Blood letting to reduce levels of ir...uce their chance of developing cancer, according t...ood have previously been linked with a lower cance...ults were based on a randomized controlled trial o...
(Date:7/8/2008)... Physicians Cite Patient Concerns about Delays in...NGTON, Va., July 8 /PRNewswire-USNewswire/ -- The ...le medical equipment has created,concern and chaos...,officials, and home medical equipment providers a...etropolitan areas on July 1., The bidding program...
Breaking Medicine News(10 mins):Health News:InsuranceSpecialists.com Looks at the Candidates and Health Reform 2Health News:InsuranceSpecialists.com Looks at the Candidates and Health Reform 3Health News:The Internet, alcohol and sleep 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 4Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 5
...s a connection between weight loss in women and th...omen had lost weight as early// as a decade before... The team analyzed nearly 560 patient histories ...drew a comparison with those who did not suffer an...
...t some links exist between Alzheimer's and Type 2 ...whether the two are actually// different forms of ... damage Type 2 diabetes causes to the pancreas is ...zheimer's on the brain. These studies were shown ...
...Nadu in promoting Indian Systems of Medicine and t...o be submitted to it in this regard // , state Hea...The state government was keen to set up an Ayurved...n this direction, he said while inaugurating a mee...
...National Pharmaceuticals Policy, industry body OPP...wth of the pharmaceutical sector // and lead to t...evious governments had reduced the number of drugs...ally to 74. The Drug Policy in February 2002 had p...
Other Medicine News:Health News:Diabetes and Alzheimer's disease May be Two Sides of the Same Coin 2
(Date:7/7/2008)...Newswire-FirstCall/ -- Biopure Corporation,(Nasdaq...ons with the Food,and Drug Administration (FDA) on...a new clinical trial of Hemopure(R) [hemoglobin gl...roposed to study use of Hemopure,in patients suffe...use,transfusion with blood components. Currently, ...
(Date:7/6/2008)...keting Authorization Application currently ..., July 7 /- Cell Therapeuti...ed the publication of results from its,randomized ...oliglumex,CT-2103) with gemcitabine or vinorelbin... patients with previously untreated non-small cell...
(Date:7/3/2008)...BRIDGE Massachusetts, July 3,/PRNewswire-FirstCall...logy company, Jerini AG for an equity purchase pr... (HAE) product, FIRAZYR(R), to its Human Genetic ...global sales expected to be around $350-400 milli...e environment, - Expected to be accretive for Non...
(Date:7/1/2008)...Regimen sNDA Targeted for Fiscal Year-end ...J., July 1, 2008 /- Eisai Corporation...efficacy data from a trial,initiated in 2002 compa...re,(BSC) in elderly patients with myelodysplastic ...atistically significant advantage of Dacogen,treat...
Breaking Medicine Technology:Biopure Announces Meeting With FDA 2Biopure Announces Meeting With FDA 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 3Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 4Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 6Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 7Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 8Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 2Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 3Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 4Mutant gene causes epilepsy intellectual disability in women 19019 1Mutant gene causes epilepsy intellectual disability in women 19019 2Key step in the puncture mechanism of cell death revealed 19016 1Key step in the puncture mechanism of cell death revealed 19016 2PLC Medical Systems to Demonstrate RenalGuard 28TM 29 at EuroPCR 2008 19013 1PLC Medical Systems to Demonstrate RenalGuard 28TM 29 at EuroPCR 2008 19013 2PLC Medical Systems to Demonstrate RenalGuard 28TM 29 at EuroPCR 2008 19013 3PLC Medical Systems to Demonstrate RenalGuard 28TM 29 at EuroPCR 2008 19013 4Diet Industry Newcomer Hits the 1 Million Unit Mark 19010 1Diet Industry Newcomer Hits the 1 Million Unit Mark 19010 2
...sented at Society for Biomolecular Sciences Confer...wire-FirstCall/ --,Lexicon Genetics Incorporated a...g potential therapeutic targets related to its,col... Biomolecular,Sciences 13th Annual Conference &...coveries were made in a collaboration,between Lexi...
... RIDGE, N.J., April 19, 2007 /PRNewswire-FirstCall...-based,biopharmaceutical company focused on acquir...r compounds, announced data from its,preclinical s...vation for the treatment of solid and hematologic ...r at the April 2007,Annual Meeting of the American...
Other Medicine Technology:Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 2Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 3Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 4Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 5VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 2VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 4VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 5
Facilitates retrieval of polypropylene guide thread from the nasal cavity when using Ritleng Bicanalicular systems and self threading Monoka systems.
...ead-guide reducing time and trauma in lacrimal duc... into the nasolacrimal duct and a thin prolene thr...hdrawn leaving the polypropylene thread to pull th... or Imperforate Nasolacrimal Duct. Silicone, Blue ...
...ead-guide reducing time and trauma in lacrimal duc... into the nasolacrimal duct and a thin prolene thr...hdrawn leaving the polypropylene thread to pull th... or Imperforate Nasolacrimal Duct. Silicone, Blue ...
For canalicular laceration or imperforate nasolacrimal duct. Medical grade silicone and Stainless Steel Probe. Box of 3, sterile. Note: Tubing securely swaged into malleable stainless steel probes. S
Medicine Products: